Ricard Ferrer, MD, PhD

Critical Care physician
Vall d’Hebron University Hospital

Disclosure: Shionogi B.V. (Individual(s) Involved: Self): Advisor or Review Panel member

Presentation(s):

• 147 - Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

  Oral Abstract